glp-1 news today october 2025 Pipeline Update: August - Prime Therapeutics π¨ BIG NEWS IN THE
Description
President Trump announced drugmakers Novo Nordisk and Eli Lilly have agreed to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound.
GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure
Ive gained some insights, too.
Your workforce likely has a growing interest (or curiosity) in GLP-1 medications
Here's what doctors have to say.
Mood & Wellness Support
